Self-management of blood pressure following a hypertensive pregnancy

Not Applicable

• Conditions: Monitoring of hypertension in women following hypertensive pregnancy; Circulatory System

• Registration Number: ISRCTN11042045
• Lead Sponsor: niversity of Oxford

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-11
• Last Update Posted: 24 June 2024
• Study Completion: 2026-12-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 628

Inclusion Criteria

1. Participant is willing and able to give informed consent for participation in the study
2. People who have recently given birth within the last 7 days
3. Aged 18 years or above
4. Participant with pregnancy hypertension including: chronic/essential hypertension (predating current pregnancy or requiring treatment before 20/40), or gestational hypertension (new-onset hypertension from 20/40 of index pregnancy) or pre-eclampsia (hypertension (GH or with proteinuria or metabolic changes), prior to their discharge from hospital post-delivery.
5. Participant still requiring antihypertensive medication at randomisation following delivery
6. Able and willing to comply with trial requirements
7. Willing to allow their primary and secondary healthcare teams, if appropriate, to be notified of participation in the trial
8. Access to a smartphone compatible with the app

Exclusion Criteria

1. Participant does not wish to self-monitor/self-manage their blood pressure
2. Participant already taking part in another trial that might affect their anti-hypertensive prescription

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean daytime ambulatory diastolic blood pressure measured using an ambulatory blood pressure monitor at 26 weeks.